|
NOTCH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.664000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.954600E-01 |
| Normal-vs-Stage2 |
2.134000E-01 |
| Normal-vs-Stage3 |
5.488600E-01 |
| Normal-vs-Stage4 |
5.522000E-01 |
| Stage1-vs-Stage2 |
2.208600E-01 |
| Stage1-vs-Stage3 |
7.843000E-01 |
| Stage1-vs-Stage4 |
7.525600E-01 |
| Stage2-vs-Stage3 |
3.828400E-01 |
| Stage2-vs-Stage4 |
4.256400E-01 |
| Stage3-vs-Stage4 |
9.576600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.443000E-01 |
| Normal-vs-AfricanAmerican |
4.025800E-01 |
| Normal-vs-Asian |
4.246600E-01 |
| Caucasian-vs-AfricanAmerican |
3.312600E-01 |
| Caucasian-vs-Asian |
4.669400E-01 |
| AfricanAmerican-vs-Asian |
1.741020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.730300E-02 |
| Normal-vs-Female |
9.574400E-01 |
| Male-vs-Female |
8.443500E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.674600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.079000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.433800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.478750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.670000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.936000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.002200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.190100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.322790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.126600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.941000E-01 |
| Classical-VS-Follicular |
9.99200722162641E-16 |
| Classical-VS-Other |
4.251600E-02 |
| Classical-VS-Normal |
2.084000E-01 |
| Tall-VS-Follicular |
6.74419999846521E-08 |
| Tall-VS-Other |
1.110440E-02 |
| Tall-VS-Normal |
3.181000E-01 |
| Follicular-VS-Other |
7.301600E-01 |
| Follicular-VS-Normal |
3.76119999589974E-08 |
| Other-VS-Normal |
1.730190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.524000E-02 |
| Normal-vs-N1 |
3.910400E-01 |
| N0-vs-N1 |
6.881600E-01 |
|
|
